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Material and Methods

Introduction
• Alzheimer’s Disease (AD) and Osteoporosis are common
degenerative diseases of aging. Previous research has found
that AD and osteoporosis may overlap [4].
• Observational studies demonstrate a correlation between the
osteoporosis and AD that suggest, rather than one condition
causing the other, both conditions are related by a common
underlying mechanism [4].
• Previous studies have investigated bone mass in mouse models
that recapitulate the pathology of AD [4].
• This study focuses on the 5xFAD mouse model, another AD
mouse model that exhibits a more aggressive form of AD.
Thus, the 5xFAD mouse model rapidly recapitulates major
features of AD amyloid pathway: rapidly accumulating Aβ42
in the brain, early amyloid deposition and gliosis, robust
intraneuronal Aβ labeling, neurodegeneration and neuron loss.
• The goal of this study was to investigate the skeleton of the
5xFAD mice and compare its bone density to age-matched
healthy control mice.

5xFAD and Wild-Type (Control) Mice Tissues
The 5xFAD mouse model is a validated model of familial Alzheimer’s
disease.
Micro-Computed Tomography (µCT)
The right femur of the wild-type (control) mice and 5xFAD mice were
scanned and analyzed using µCT. Trabecular bone architecture was
measured in a proximal region. Primary trabecular parameters included
bone volume per total volume (BV/TV). Cortical geometry was measured
in a 100 slice region at the midshaft at 50% of the total length of the femur.
Primary cortical parameter includes cortical area (mm2).
Bone Histological Analysis:
After µCT scanning, the bones were prepared for histological investigation
by dehydration and decalcification of the femoral tissues. After all the
calcium from bones were removed, samples were embedded in paraffin,
cut into sections and mounted for tartrate-resistant acid phosphatase
(TRAP) and Sudan Black B staining.

Results and Discussion
Figure 1: X-ray scan of the Femurs.
The left image displays an X-ray of a
Wild-Type mice femur. The right image
displays an X-ray of a 5xFAD transgenic
mice femur.

Figure 7: Tartrate Resistant Acid
Phosphatase (TRAP) Staining for
Osteoclasts.

Figure 4: 3D Reconstruction of µCT Scanned Trabecular Bone.
Figure 2: Trabecular Bone Volume per
Total Volume (BV/TV) Comparison.

Figure 3: Trabecular Bone Volume per Total
Volume (BV/TV) Comparison.

Trabecular Bone
Male 5xFAD mice exhibit a decrease in
trabecular bone density over time in
contrast to Wild-Type (WT) mice
(Figure 3). Older female 5xFAD mice
exhibit a lower trabecular bone density
than the WT mice.

Figure 8: Sudan Black B
(SBB) senescence Staining.

• The data suggest that 5xFAD mouse model
Figure 5: Cortical Area of Femur Bone
recapitulates the low bone mass
characteristics of osteoporosis
• The change in bone density over time
observed in the 5xFAD mice suggest that the
bone mass loss is progressive
• The data and images collected from the study
provide evidence to suggest that the
combination of mutations in the diseased
Figure 6: Cortical Area of Femur Bone
5xFAD mice have an effect on the bone
Cor$cal Bone
resorption of the trabecular bone in the
μCT analyses show that over
5xFAD mice in comparison to the WT mice
1me male 5xFAD mice do not
have a decreased cor1cal bone (Figure 1,4).
are in comparison with WT
• Male 5xFAD mice do not experience cortical
mice. Older female mice
bone resorption to the same extent observed
exhibit a lower cor1cal bone
in female mice (Figure 5, 6).
area than WT mice.

Conclusion and Future Work
• We are currently
performing TRAP
staining, which is a
method to identify
active osteoclasts.

• Considering other mouse models that recapitulate AD
exhibit similar effects in trabecular and cortical bone, our
current model could share the same mechanisms and
pathologies that are driving the effects seen in those mouse
models. Future work is necessary to identify the role of Aβ
and RANKL Pathway in the 5xFAD model.

• We are also performing Sudan •
Black staining to investigate
senescence, a process known
to occur in the brains of AD
patients, to understand
whether the bone resorption is
due to cellular aging.
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